Summary of findings 2. Summary of findings: Compensative interventions versus control.
Compensative interventions compared with control for visual field defects in patients with stroke | ||||
Patient or population: stroke survivors with visual field defects Settings: any rehabilitation setting Intervention: compensative interventions Comparison: control, placebo, or no intervention | ||||
Outcomes | Relative effect (95% CI) | No of Participants (studies) | Quality of the evidence (GRADE) | Comments |
Functional ability in activities of daily living | (no data) | No studies | Insufficient evidence | |
Visual field (Functional field score and relative change in visual field score, combined) After intervention |
SMD ‐0.11 (‐0.92 to 0.70 (no significant effect) |
95 (2 studies, De Haan 2015; Rowe 2010) |
⊕⊝⊝⊝ very low | Reasons for downgrades:
|
Extended activities of daily living (Mobility questionnaire and change in Nottingham EADL, combined) After intervention |
SMD 0.49 (‐0.01 to 0.99) (no significant effect) |
97 (2 studies, De Haan 2015; Rowe 2010) |
⊕⊝⊝⊝ very low | Reasons for downgrades:
s |
Reading ability (Reading speed; various tests) After intervention |
SMD 0.26 (‐0.05 to 0.58) (no significant effect) |
162 (4 studies, Aimola 2011; De Haan 2015; Rowe 2010; Spitzyna 2007) |
⊕⊕⊝⊝ low | Reasons for downgrades:
|
Falls | (no data) | No studies | Insufficient evidence | |
Quality of life (National Eye Institute Visual Function Questionnaire (NEI ‐ VFQ‐25) total score) After intervention |
MD 9.36 (3.10 to 15.62) (favours compensatory) |
96 (2 studies, De Haan 2015; Rowe 2010) |
⊕⊕⊝⊝ low | Reasons for downgrades:
|
Scanning ‐ cancellation (cancellation tests ‐ time to complete) After intervention |
SMD ‐0.01 (‐0.40 to 0.39) (no significant effect) |
97 (2 studies, Aimola 2011; De Haan 2015) |
⊕⊕⊝⊝ low | Reasons for downgrades:
|
Adverse events (number of participants with reported events during intervention period) |
OR 5.18 (0.24 to 112.57 (favours control) |
108 (2 studies, De Haan 2015; Rowe 2010) (NB. no events recorded in De Haan 2015, which did not explicitly report adverse events as an outcome measure) |
⊕⊕⊝⊝ low | Reason for downgrades:
|
GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate. |
CI: confidence intervals EADL: extended activities of daily living MD: mean difference NEI‐VFQ‐25: National Eye Institute Visual Function Questionnaire OR: odds ratio SMD: standardised mean difference